tiprankstipranks
Elicio Therapeutics (ELTX)
NASDAQ:ELTX

Elicio Therapeutics (ELTX) Stock Investors

185 Followers
Based on 746,803 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold ELTX
On average, investors allocate 0.00% of their portfolios to ELTX
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 746,803 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding ELTX

1.7%
Last 7
Days
6.6%
Last 30
Days
Percentages indicate the change in the number of portfolios holding ELTX, out of 746,803 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

ELTX Investor Activity

Action
Any
Any
Investor Performance
Any
Any
No data currently available
Based on the activity of 14,175 investors who made their portfolios public
The table shows changes in ELTX in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

ELTX Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
DraftKings
5.86%
-1.32%
-1.44%
34.65B
Consumer Cyclical
ChargePoint Holdings
4.22%
-1.16%
-2.22%
927.16M
Consumer Cyclical
Marathon Digital Holdings
5.79%
-0.34%
+0.22%
6.71B
Financial
Blink Charging Co
5.22%
-1.41%
-4.28%
350.68M
Industrials
Coherus Biosciences
2.56%
-1.64%
-4.99%
189.30M
Healthcare
Assertio Therapeutics
2.87%
-1.66%
-4.86%
146.49M
Healthcare
AMC Entertainment
5.72%
-1.86%
-3.28%
1.58B
Communication Services
Riot Platforms
5.08%
-0.61%
+0.89%
3.32B
Financial
XPeng, Inc. ADR
5.32%
-1.58%
-2.99%
7.94B
Consumer Cyclical
Applied Materials
4.70%
+0.22%
+6.34%
203.31B
Technology
Based on the activity of 746,803 active portfolios
Open your Smart Portfolio

ELTX Investor Analysis

ELTX investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
9.2%
of ELTX holders
are under 35
Average Segment Performance
Average P/E Ratio21.96
Beta7.16
Dividend Yield6.43%
ELTX investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
41.5%
of ELTX holders
are between 35–55
Average Segment Performance
Average P/E Ratio20.75
Beta11.80
Dividend Yield6.41%
ELTX investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
49.2%
of ELTX holders
are over 55
Average Segment Performance
Average P/E Ratio20.82
Beta3.95
Dividend Yield7.83%
Overview of age group and performance of ELTX stock investors
See who invests in ELTX according to age group and performance.

FAQ

How many retail Investors hold ELTX?
<0.1% of TipRanks' retail investors hold ELTX in their portfolios.
    What is ELTX Investor Sentiment?
    ELTX’s Investor Sentiment is Very Positive.
      What percentage of retail investors changed their holding of ELTX in the last 7 days?
      ▼ 1.7% of TipRanks' retail investors changed their holding of ELTX in the last 7 days.
        What percentage of retail investors changed their holding of ELTX in the last 30 days?
        ▲ 6.6% of TipRanks' retail investors changed their holding of ELTX in the last 30 days.
          What is the average age of retail investors who hold ELTX?
          The average age of ELTX Holders is over 55.
            What other stocks have ELTX investors also bought?
            ELTX Investors also bought DKNG, CHPT, MARA, BLNK, CHRS, ASRT, AMC, RIOT, XPEV, AMAT.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              BCRXBioCryst
              BSXBoston Scientific
              CYTKCytokinetics
              EWEdwards Lifesciences
              AVDLAvadel Pharmaceuticals
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis